title: Vibrio vulnificus biotype 2 serovar E gne but not galE is essential for lipopolysaccharide biosynthesis and virulence.
abstract: This work aimed to establish the role of gne (encoding UDP-GalNAc 4-epimerase activity) and galE (encoding UDP-Gal-4-epimerase activity) in the biosynthesis of surface polysaccharides, as well as in the virulence for eels and humans of the zoonotic serovar of Vibrio vulnificus biotype 2, serovar E. DNA sequence data revealed that gne and galE are quite homologous within this species (> or =90% homology). Mutation in gne of strain CECT4999 increased the surface hydrophobicity, produced deep alterations in the outer membrane architecture, and resulted in noticeable increases in the sensitivity to microcidal peptides (MP), to eel and human sera, and to phagocytosis/opsonophagocytosis. Furthermore, significant attenuation of virulence for eels and mice was observed. By contrast, mutation in galE did not alter the cellular surface, did not increase the sensitivity to MP, serum, or phagocytosis, and did not affect the virulence for fish and mice. The change in the attenuated-virulence phenotype produced by a mutation in gne was correlated with the loss of the O-antigen lipopolysaccharide (LPS), while the capsule was maintained. Complementation of a gne-deficient mutant restored the LPS structure together with the whole virulence phenotype. In conclusion, gne, but not galE, is essential for LPS biosynthesis and virulence in the zoonotic serovar of V. vulnificus biotype 2.
authors.affiliation: Departamento de Microbiología y Ecología, Universidad de Valencia, c/ Dr. Moliner, 50, Burjasot, Valencia, Spain.
authors.forename: Esmeralda
authors.initials: E
authors.lastname: Valiente
authors.forename: Natalia
authors.initials: N
authors.lastname: Jiménez
authors.forename: Susana
authors.initials: S
authors.lastname: Merino
authors.forename: Juan M
authors.initials: JM
authors.lastname: Tomás
authors.forename: Carmen
authors.initials: C
authors.lastname: Amaro
mesh_terms: D000818:Animals; D023181:Antimicrobial Cationic Peptides / Q000494:pharmacology; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D001483:Base Sequence; D018441:Biofilms; D002238:Carbohydrate Epimerases / Q000235:genetics / Q000378:metabolism*; D002633:Chemotaxis; D003001:Cloning, Molecular; D004524:Eels; D015964:Gene Expression Regulation, Bacterial; D008070:Lipopolysaccharides / Q000096:biosynthesis*; D051379:Mice; D008969:Molecular Sequence Data; D009154:Mutation; D010586:Phagocytes / Q000502:physiology; D010587:Phagocytosis; D014168:Transferrin / Q000494:pharmacology; D014534:UDPglucose 4-Epimerase / Q000235:genetics / Q000378:metabolism*; D041261:Vibrio vulnificus / Q000187:drug effects / Q000235:genetics / Q000378:metabolism* / Q000472:pathogenicity*; D014774:Virulence
chemical_list: D023181:Antimicrobial Cationic Peptides; D001426:Bacterial Proteins; D008070:Lipopolysaccharides; D014168:Transferrin; D002238:Carbohydrate Epimerases; C023223:UDP-N-acetylglucosamine 4-epimerase; D014534:UDPglucose 4-Epimerase; C020551:galactose epimerase